Expanding the number of treatable intellectual disabilities through an integrated "-omics" approach

通过综合“组学”方法扩大可治疗智力障碍的数量

• 批准号: 281094
• 负责人: van Karnebeek Clara D
• 金额: $ 56.31万
• 依托单位: BC Children's Hospital Research Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-03-01 至 2018-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=281094&lang=en
• 关键词: Discovery; Global Developmental Delay; Inborn Errors Of Metabolism; Intellectual Disability; Knowledge Translation; Metabolomics; Whole Exome Sequencing

Intellectual disability (ID) affects 2-3% of children and adults, or 140-210 million people worldwide. Defined strictly as low IQ, ID can have devastating lifelong effects on all aspects of life. The health cost of ID equals that of stroke, heart disease

智力残疾（ID）影响着2-3%的儿童和成人，或全球1.4 - 2.1亿人。严格定义为低智商，ID可以对生活的各个方面产生毁灭性的终身影响。ID的健康成本等于中风，心脏病